TY  - SER
AU  - Marincola,Francesco
ED  - SpringerLink (Online service)
TI  - Translational Medicine Communications
SN  - 2396-832X
CY  - London
PB  - BioMed Central, Imprint: BioMed Central.
KW  - Medicine—Research
KW  - Biology—Research
KW  - Public health
KW  - Medical sciences
KW  - Drug development
KW  - Immunology
KW  - Oncology
KW  - Biomedical Research
KW  - Public Health
KW  - Preclinical Research
KW  - Translational Research
KW  - Translational Immunology
N2  - Translational Medicine Communications will cease to be published by BioMed Central as of 31st December 2024. BMC will continue to host an archive of all articles published in Translational Medicine Communications and it will remain fully searchable via the BMC website. You can view all the published articles here. Translational Medicine Communications is an interdisciplinary forum for all scientifically valid research from across translational medicine. We publish research that focuses on the biology of disease, as well as preclinical and basic research that is closely associated with medicine. Translational Medicine Communications will also consider reviews, methodology articles, protocols and commentaries. Our aim is to improve transparency and reproducibility within translational medicine, which is why we consider research papers regardless of outcome or significance of findings, as well as protocols for future research. We aim to serve the translational science community by publishing all scientifically valid and technically sound articles and we are dedicated to facilitating the communication between basic and clinical science
UR  - https://transmedcomms.biomedcentral.com
ER  -